Process for the preparation of 17.alpha.-bromoethynyl- and
17.alpha.-iodoethynyl-17.beta.-hydroxy steroids and novel products
thereof
    44.
    发明授权
    Process for the preparation of 17.alpha.-bromoethynyl- and 17.alpha.-iodoethynyl-17.beta.-hydroxy steroids and novel products thereof 失效
    制备17α-溴乙炔基 - 和17α-碘代乙炔基-ββ-羟基类固醇的方法及其新产物

    公开(公告)号:US4550100A

    公开(公告)日:1985-10-29

    申请号:US552537

    申请日:1983-11-16

    摘要: A process for preparing bromine- or iodine-unlabeled or radioactively labeled 17.alpha.-bromoethynyl- and 17.alpha.-iodoethynyl-17.beta.-hydroxy steroids of the androstane and estrane series of the partial formula ##STR1## wherein is a single bond or a double bond,V is a carbon-carbon bond or a methylene group,R is hydrogen or methyl, andX is bromine or iodine,from corresponding 17.alpha.-ethynyl-17.beta.-hydroxy steroids, comprises treating the starting steroid in an inert solvent with a brominating agent or an iodinating agent in the presence of a silver salt.The process enables production of old and new compounds having value as pharmacologically active compounds and also as diagnostic agents when the iodine or bromine is radioactive.

    摘要翻译: 制备溴或碘未标记或放射性标记的17α-溴乙炔基 - 和17α-碘代乙炔基-17β-羟基类固醇的方法,所述甾族化合物和部分分子式“IMAGE”的雌激素系列是单键或双重 键,V是碳 - 碳键或亚甲基,R是氢或甲基,X是溴或碘,来自相应的17α-乙炔基-17β-羟基类固醇,包括在惰性溶剂中处理起始类固醇, 溴化剂或碘化剂在银盐存在下进行。 该方法能够生产具有价值作为药理活性化合物的老化合物和新化合物,并且当碘或溴是放射性时也可以作为诊断剂。

    17.alpha.-HYDROXY-1,3,5(10),15-ESTRATETRAENES AND PROCESS FOR THEIR
PRODUCTION
    49.
    发明授权
    17.alpha.-HYDROXY-1,3,5(10),15-ESTRATETRAENES AND PROCESS FOR THEIR PRODUCTION 失效
    17 {60-羟基-1,3,5(10),15-ESTRATETRAENES及其生产方法

    公开(公告)号:US4016269A

    公开(公告)日:1977-04-05

    申请号:US603773

    申请日:1975-08-11

    IPC分类号: C07J1/00 C07J17/00 A61K31/58

    CPC分类号: C07J1/0062 C07J17/00

    摘要: Novel estrogenic 17.alpha.-hydroxy-1,3,5(10),15-estratetraenes of the formula ##STR1## wherein R.sub.1 is H, lower alkyl or lower acyl, R.sub.2 is lower alkyl and R.sub.3 is H, lower alkyl, lower acyl or tetrahydropyranyloxy, are produced by (a) reacting a 16.alpha.,17.alpha.-epoxy-estratriene with lithium halide or HCl in glacial acetic acid; converting the resulting halohydrin into a 16-halo-17-tetrahydropyranyl ether; and splitting off hydrogen halide from therefrom; or (b) reacting the 16.alpha.,17.alpha.-epoxy-estratriene with diphenylselenide and alkali metal borohydride; oxidizing the thus-produced 17.alpha.-hydroxy-16.beta.-phenylselenide to the corresponding phenylselenide oxide; and forming the .DELTA..sup.15 double bond by heating with removal of phenyl--Se--OH.

    摘要翻译: 其中R 1是H,低级烷基或低级酰基,R 2是低级烷基,R 3是H,低级烷基,低级酰基,低级烷基,低级酰基, (a)使16α,17α-环氧 - 雌三醇与卤代卤化物或HCl在冰醋酸中反应制备; 将所得卤代醇转化为16-卤代-17-四氢吡喃基醚; 并从其中分离卤化氢; 或(b)使16α,17α-环氧 - 雌三烯与二苯基硒和碱金属硼氢化物反应; 将由此产生的17α-羟基-16β-苯基硒化物氧化成相应的苯基硒化物氧化物; 并通过除去苯基-Se-OH加热形成DELTA 15双键。

    Pregnane-21-oic acid derivatives
    50.
    发明授权
    Pregnane-21-oic acid derivatives 失效
    孕烯-21-酸衍生物

    公开(公告)号:US4008312A

    公开(公告)日:1977-02-15

    申请号:US626775

    申请日:1975-10-29

    IPC分类号: C07J71/00 A61K31/58 C07J1/00

    CPC分类号: C07J71/0026

    摘要: Pregnane-21-oic acid derivatives of the formula ##STR1## wherein THE LINKAGE REPRESENTS A SINGLE BOND OR A DOUBLE BOND;X is hydrogen, fluorine or chlorine;Y is methylene, hydroxymethylene, alkanoyloxymethylene, carbonyl, fluoromethylene or chloromethylene;R.sub.1 is hydrogen, alkyl of 1-6 carbon atoms, phenyl or naphthyl substituted with 0-3 lower alkyl, lower alkoxy or chlorine; andR.sub.2 represents a hydrogen atom, the cation of a physiologically compatible base or the residue of a physiologically acceptable alcohol of 1-18 carbon atoms.These compounds exhibit useful antiinflammatory activity when topically applied to inflamed skin.

    摘要翻译: 式“IMAGE”的孕烷-21-酸衍生物,其中链接代表单键或双键; X为氢,氟或氯; Y是亚甲基,羟基亚甲基,烷酰氧基亚甲基,羰基,氟亚甲基或氯代亚甲基; R1是氢,1-6个碳原子的烷基,被0-3个低级烷基,低级烷氧基或氯取代的苯基或萘基; R2表示氢原子,生理上相容的碱的阳离子或1-18个碳原子的生理上可接受的醇的残基。